发明名称 1H-BENZIMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS
摘要 The disclosure is directed to the use of compounds of formula (I), wherein R1, R6, R8, Q2, Q3, Q3a, Q4, L and A have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation and/or cancer some diseases treated include asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, inflammatory bowel disease, irritable bowel syndrome, pain, inflammatory pain, fever, migraine, headache, low back pain, fibromyalgia, a myofascial disorder, a viral infection, a bacterial infection, a fungal infection, dysmenorrhea, a burn, a surgical or dental procedure, a malignancy, hyperprostaglandin B syndrome, classic Bartter syndrome, atherosclerosis, gout, arthritis, osteoarthritis, juvenile arthritis, rheumatoid arthritis, rheumatic fever, ankylosing spondylitis, Hodgkin's disease, systemic lupus erythematosus, vasculitis, pancreatitis, nephritis, bursitis, conjunctivitis, iritis, scleritis, uveitis, wound healing, dermatitis, eczema, psoriasis, stroke, diabetes mellitus, a neurodegenerative disorder, an autoimmune disease, an allergic disorder, rhinitis, an ulcer, coronary heart disease, sarcoidosis, any other disease with an inflammatory component, osteoporosis, osteoarthritis, Paget's disease, a periodontal disease . Further a selection of compounds of formula (I) are claimed. Examples of compounds of formula (I) include: N-(4-Bromophenyl)-2-(3,5-dichloropyridin-4-ylamino)-1H-benzimidazole-5-carboxamide, 2-(3,5-Dichloropyridin-4-ylamino)-N-(4,4-dimethylcyclohexyl)-1H-benzimidazole-6-carboxamide, N-(4-Bromophenyl)-2-(3,5-dichloropyridin-4-ylamino)-1-methyl-1H-benzimidazole-5-carboxamide, N-(4-Bromophenyl)-1-methyl-2-(3-trifluoromethyl-pyridin-4-ylamino)-1H-benzimidazole-5-carboxamide and 2-(3,5 -Dichloropyridin-4-ylamino)-N-(4-bromo-phenyl)-6-ethoxy-1-(2,2,2-trifluoroethoxy)-1H-benzimidazole-6-carboxamide. MED14113418 MED14113418 MED14113418
申请公布号 NZ591846(A) 申请公布日期 2012.11.30
申请号 NZ20090591846 申请日期 2009.09.25
申请人 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 发明人 PFAU, ROLAND;ARNDT, KIRSTEN;DOODS, HENRI;HAUEL, NORBERT;KLINDER, KLAUS;KUELZER, RAIMUND;MACK, JUERGEN;STENKAMP, DIRK
分类号 A61K31/4184;A61P11/00;A61P29/00;C07D401/12;C07D401/14;C07D405/14 主分类号 A61K31/4184
代理机构 代理人
主权项
地址